InvestorsHub Logo
Followers 155
Posts 2642
Boards Moderated 0
Alias Born 01/29/2004

Re: BAR123 post# 442270

Monday, 12/11/2023 3:01:54 PM

Monday, December 11, 2023 3:01:54 PM

Post# of 462187
What Could This Guy Be Thinking (or Know)?

So, after several others recently, another experienced drug science professional, one Dr. Jeffrey Edwards, signs on with Anavex Life Sciences Corp, as Vice President of Clinical Pharmacology. From LinkedIn, here are Dr. Edward’s previous drug company positions:

Vice President of Clinical ScienceVice President of Clinical Science

Acer Therapeutics Inc.

Vice President of Clinical Science
Madrigal Pharmaceuticals

Executive Director of Clinical and Preclinical Pharmacology
Intercept Pharmaceuticals

Director of Clinical Pharmacology and DMPK
Intercept Pharmaceuticals

Principal Investigator
Amylin Pharmaceuticals

Associate Director, Senior Scientist, Scientist II, Scientist
Arena Pharmaceuticals

https://www.linkedin.com/in/jeffrey-edwards-07b0844a/details/experience/

Before Dr. Edwards signed on with Anavex, any chance that he first demanded to scrutinize all of the data Anavex has relevant to the potential approval of their candidate drugs? If those clinical results data are as bad as the Anavex naysayers tell us on this message board, why would he then decide to sign on to a sure-to-fail start-up biotech?

Who’ya gonna believe?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News